u/Away_Cancel_5208 · 113d ago1 prior · 50% at 3mo
Long BNTX $100C exp Jun 18
BNTX is about to go full send at ASCO and nobody’s talking about it 🚀🧬
BioNTech will present multiple late-stage clinical readouts at ASCO 2026 starting May 29th, with pumitamig (PD-L1 + VEGF-A bispecific) potentially rivaling Keytruda in lung cancer. Positive Phase 2 data would unlock a multi-product oncology empire narrative and phase in $16.8B cash runway, driving upside.
At post $88.85Now $98.66+11.0% since postedas of Sep 8, 4:30 PM ET
1d-1.2%
3d+2.3%
1w+3.7%
1m+3.9%
3m+4.8%
6m—
1y—